Keryx Biopharmaceuticals recalls
Keryx Biopharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 22 Jul 2020.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 22 Jul 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why keryx biopharmaceuticals is recalled
By year
All keryx biopharmaceuticals recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Auryxia (ferric citrate) tablets 210 mg recalledAuryxia | Keryx Biopharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Auryxia (ferric citrate) tablets, 210 mg recalledAuryxia | Keryx Biopharmaceuticals | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.